Protein 1 | Protein 2 | Combine Score |
---|---|---|
CPLX2 | SNAP25 | 0.956 |
CPLX2 | CPLX4 | 0.927 |
# | 6616 (SNAP25) | 339302 (CPLX4) | 10814 (CPLX2) |
---|---|---|---|
6616 (SNAP25) | 1.00 | 0.84 | 0.83 |
339302 (CPLX4) | 0.84 | 1.00 | 1.00 |
10814 (CPLX2) | 0.83 | 1.00 | 1.00 |
Protein Official symbol | Source Organism | Tissue of Expression | Level of hypoxia | Altitude | Duration of experiment | Level of expression | Fold change | Experiment details | geographical location | ethnicity of the patients | Control group | Control (Fold change) | Reference (PMID) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CPLX2 | Rat | Left brain cortices | 300hPa | 9144 m | 1 hour | upregulated | 1.15±0.4 | TMT labeled LTQ orbitrap | Southwestern europe | Male wistar rats | 1 | Adult male Wistar rats weighing 350 g | 28697276 |
miRTarBase ID | miRNA | Species (miRNA) | Protein Official Symbol | Human Entrez ID | Species (Target Gene) | Experiments | Support Type | References (PMID) |
---|---|---|---|---|---|---|---|---|
MIRT713796 | hsa-miR-3622b-3p | Homo sapiens | CPLX2 | 10814 | Homo sapiens | HITS-CLIP | Functional MTI (Weak) | 19536157 |
MIRT713797 | hsa-miR-3622a-3p | Homo sapiens | CPLX2 | 10814 | Homo sapiens | HITS-CLIP | Functional MTI (Weak) | 19536157 |
MIRT713798 | hsa-miR-1306-5p | Homo sapiens | CPLX2 | 10814 | Homo sapiens | HITS-CLIP | Functional MTI (Weak) | 19536157 |
MIRT713799 | hsa-miR-574-3p | Homo sapiens | CPLX2 | 10814 | Homo sapiens | HITS-CLIP | Functional MTI (Weak) | 19536157 |
MIRT713795 | hsa-miR-6765-3p | Homo sapiens | CPLX2 | 10814 | Homo sapiens | HITS-CLIP | Functional MTI (Weak) | 19536157 |
ID | GO ID | GO Term | GO Type |
---|---|---|---|
10814 | GO:0007399 | nervous system development | GOTERM_BP_DIRECT |
10814 | GO:0043025 | neuronal cell body | GOTERM_CC_DIRECT |
10814 | GO:0070554 | synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex | GOTERM_CC_DIRECT |
10814 | GO:0006836 | neurotransmitter transport | GOTERM_BP_DIRECT |
10814 | GO:0031915 | positive regulation of synaptic plasticity | GOTERM_BP_DIRECT |
10814 | GO:0043303 | mast cell degranulation | GOTERM_BP_DIRECT |
10814 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex | GOTERM_CC_DIRECT |
10814 | GO:0030154 | cell differentiation | GOTERM_BP_DIRECT |
10814 | GO:0005829 | cytosol | GOTERM_CC_DIRECT |
10814 | GO:0006904 | vesicle docking involved in exocytosis | GOTERM_BP_DIRECT |
10814 | GO:0017157 | regulation of exocytosis | GOTERM_BP_DIRECT |
10814 | GO:0048306 | calcium-dependent protein binding | GOTERM_MF_DIRECT |
10814 | GO:0042629 | mast cell granule | GOTERM_CC_DIRECT |
10814 | GO:0030425 | dendrite | GOTERM_CC_DIRECT |
10814 | GO:0043195 | terminal bouton | GOTERM_CC_DIRECT |
10814 | GO:0016079 | synaptic vesicle exocytosis | GOTERM_BP_DIRECT |
10814 | GO:0017075 | Rho GTPase binding | GOTERM_MF_DIRECT |
Human Entrez ID | KEGG ID | KEGG Term |
---|---|---|
10814 | hsa04721 | Synaptic vesicle cycle |
Protein Official Symbol | Human Entrez ID | Disease Name | Disease Id | Disease Semantic Type | Semantic score | DSI | DPI | Disease Type |
---|---|---|---|---|---|---|---|---|
CPLX2 | 10814 | Psychotic Disorders | C0033975 | Mental or Behavioral Dysfunction | 0.3 | 0.713 | 0.172 | group |
CPLX2 | 10814 | Schizoaffective Disorder | C0036337 | Mental or Behavioral Dysfunction | 0.3 | 0.713 | 0.172 | disease |
CPLX2 | 10814 | Depression, Bipolar | C0005587 | Mental or Behavioral Dysfunction | 0.3 | 0.713 | 0.172 | disease |
CPLX2 | 10814 | Bipolar Disorder | C0005586 | Mental or Behavioral Dysfunction | 0.3 | 0.713 | 0.172 | disease |
CPLX2 | 10814 | Psychosis, Brief Reactive | C0033958 | Mental or Behavioral Dysfunction | 0.3 | 0.713 | 0.172 | disease |
CPLX2 | 10814 | Manic Disorder | C0024713 | Mental or Behavioral Dysfunction | 0.3 | 0.713 | 0.172 | disease |
CPLX2 | 10814 | Manic | C0338831 | Mental or Behavioral Dysfunction | 0.3 | 0.713 | 0.172 | disease |
CPLX2 | 10814 | Schizophrenia | C0036341 | Mental or Behavioral Dysfunction | 0.38 | 0.713 | 0.172 | disease |
CPLX2 | 10814 | Schizophreniform Disorders | C0036358 | Mental or Behavioral Dysfunction | 0.3 | 0.713 | 0.172 | group |
CPLX2 | 10814 | Depressive disorder | C0011581 | Mental or Behavioral Dysfunction | 0.31 | 0.713 | 0.172 | disease |
CPLX2 | 10814 | Mental Depression | C0011570 | Mental or Behavioral Dysfunction | 0.31 | 0.713 | 0.172 | disease |
Protein Official Symbol | Human Entrez ID | drug_claim_primary_name | drug_name | drug_chembl_id | interaction_types |
---|